Evidence map›Paper›PMID 21371038›Full record

ArticleJournal of neurochemistry2011

Group I mGluR-regulated translation of the neuronal glutamate transporter, excitatory amino acid carrier 1.

John R Ross, Hariharasubramanian Ramakrishnan, Brenda E Porter, Michael B Robinson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

John R RossDepartments of Pediatrics and Pharmacology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.
Hariharasubramanian Ramakrishnan
Brenda E Porter
Michael B Robinson
Children's Hospital of Philadelphia · USPhiladelphia University · USUniversity of Pennsylvania · US

Funding

TRANSGENIC MOUSE MODELS OF MENTAL RETARDATIONP30HD026979 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI YUDKOFF, MARC · 1990 to 2015
$15.3M
CRE Mediated Transcription in EpileptogenesisR01NS056222 · NINDS · STANFORD UNIVERSITY · PI PORTER, BRENDA ELAINE · 2008 to 2012
$2.0M
Regulation of Extracellular ExcitotoxinsR01HD060132 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBINSON, MICHAEL BYRNE · 2008 to 2012
$1.7M
Predoctoral Fellowship for Minority StudentsF31NS049690 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI ROSS, JOHN R · 2004 to 2008
$200k
NICHD NIH HHS P30 HD026979NICHD NIH HHS P30 HD26979NICHD NIH HHS R01 HD060132NINDS NIH HHS F31 NS049690NINDS NIH HHS R01 NS056222
6 · The paper itself

Abstract

Recently, we demonstrated that mRNA for the neuronal glutamate transporter, excitatory amino acid carrier 1 (EAAC1), is found in dendrites of hippocampal neurons in culture and in dendrites of hippocampal pyramidal cells after pilocarpine-induced status epilepticus (SE). We also showed that SE increased the levels of EAAC1 mRNA ~15-fold in synaptoneurosomes. In this study, the effects of SE on the distribution EAAC1 protein in hippocampus were examined. In addition, the effects of Group 1 mGluR receptor activation on the levels of EAAC1 protein were examined in synaptoneurosomes prepared from sham control animals and from animals that experience pilocarpine-induced SE. We find that EAAC1 immunoreactivity increases in pyramidal cells of the hippocampus after 3 h of SE. In addition, the group I mGluR agonist, (S)-3,5-dihydroxyphenylglycine (DHPG), caused an increase in EAAC1 protein levels in hippocampal synaptoneurosomes; this effect of DHPG was much larger (~3- to 5-fold) after 3 h of SE. The DHPG-induced increases in EAAC1 protein were blocked by two different inhibitors of translation but not by inhibitors of transcription. mGluR1 or mGluR5 antagonists completely blocked the DHPG-induced increases in EAAC1 protein. DHPG also increased the levels of glutamate receptor 2/3 protein, but this effect was not altered by SE. The DHPG-induced increase in EAAC1 protein was blocked by an inhibitor of the mammalian target of rapamycin or an inhibitor of extracellular signal-regulated kinase. These studies provide the first evidence EAAC1 translation can be regulated, and they show that regulated translation of EAAC1 is up-regulated after SE.

Indexed as

AnimalsBlotting, WesternConvulsantsDendritesDose-Response Relationship, DrugExcitatory Amino Acid Transporter 3Extracellular Signal-Regulated MAP KinasesFluorescent Antibody TechniqueHippocampusMaleMethoxyhydroxyphenylglycolNeuronsPilocarpinePyridinesRatsRats, Sprague-Dawley3,4-dihydroxyphenylglycol6-methyl-2-(phenylethynyl)pyridineConvulsantsExcitatory Amino Acid Transporter 3Extracellular Signal-Regulated MAP KinasesGrm5 protein, ratmetabotropic glutamate receptor type 1MethoxyhydroxyphenylglycolmTOR protein, ratPilocarpinePyridinesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateRNA, MessengerSlc1a1 protein, ratTOR Serine-Threonine Kinases

Identifiers

PMID21371038
PMCPMC3088777
OpenAlexW1481296049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.